Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
Jennifer T Leahy1, Catherine J Chu-Shore1,2, Janet L Fisher3 1Massachusetts General Hospital, Department of Neurology, Programs in Neurophysiology and Epilepsy, Boston, MA, 2Harvard Medical School, Boston, MA, 3University of South Carolina School of Medicine, Department of Pharmacology, Physiology a...
Enregistré dans:
Auteurs principaux: | Leahy JT, Chu-Shore CJ, Fisher JL |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2746b29c57814b9d8801f6779cc0802c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
par: Jessica Gresham, et autres
Publié: (2010) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
par: Balagura G, et autres
Publié: (2020) -
Treatment of Lennox-Gastaut syndrome: overview and recent findings
par: Kenou van Rijckevorsel
Publié: (2008) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
par: Carl E Stafstrom
Publié: (2009) -
Rufinamide in patients with Lennox-Gastaut syndrome
par: Clark PO, et autres
Publié: (2016)